The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131
 
Ingrid A. Mayer
No Relationships to Disclose
 
Fengmin Zhao
No Relationships to Disclose
 
Carlos L. Arteaga
No Relationships to Disclose
 
William Fraser Symmans
No Relationships to Disclose
 
Ben Ho Park
No Relationships to Disclose
 
Brian Leslie Burnette
No Relationships to Disclose
 
Amye Juliet Tevaarwerk
No Relationships to Disclose
 
Sofia F. Garcia
No Relationships to Disclose
 
Karen L. Smith
No Relationships to Disclose
 
Erica L. Mayer
No Relationships to Disclose
 
William M. Sikov
No Relationships to Disclose
 
Eve T. Rodler
No Relationships to Disclose
 
Lynne I. Wagner
No Relationships to Disclose
 
Angela DeMichele
No Relationships to Disclose
 
Joseph A. Sparano
No Relationships to Disclose
 
Antonio C. Wolff
No Relationships to Disclose
 
Kathy Miller
No Relationships to Disclose